PERSPECTIVE
Accepted on 20 Jan 2025
How we got to now: Six events that shaped antibody approvals in oncology Working title: Key events in antibody-drug approvals
doi 10.3389/fimmu.2025.1533796
- 113 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- The Next Stage of Immune Cell Design: Selective Targeting of Multi-Antigen Profiles
The Next Stage of Immune Cell Design: Selective Targeting of Multi-Antigen Profiles
2,510
Total downloads
9,232
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 13 Dec 2024
In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models
doi 10.3389/fimmu.2024.1501365
- 1,468 views
REVIEW
Published on 13 Nov 2024
Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies
doi 10.3389/fimmu.2024.1490911
- 2,195 views
PERSPECTIVE
Published on 07 Nov 2024
Identifying optimal tumor-associated antigen combinations with single-cell genomics to enable multi-targeting therapies
doi 10.3389/fimmu.2024.1492782
- 1,270 views
ORIGINAL RESEARCH
Published on 19 Jul 2024
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
doi 10.3389/fimmu.2024.1407567
- 1,622 views
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- T Cell Biology
- NK and Innate Lymphoid Cell Biology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 9,232Topic views
- 6,160Article views
- 2,510Article downloads